The Probiotics in Pediatric Asthma Management (PROPAM) Study in the Primary Care Setting: A Randomized, Controlled, Double-Blind Trial with <i>Ligilactobacillus salivarius</i> LS01 (DSM 22775) and <i>Bifidobacterium breve</i> B632 (DSM 24706)

Journal of Immunology Research

fig1

Figure 1

Figure 1: The Probiotics in Pediatric Asthma Management (PROPAM) Study in the Primary Care Setting: A Randomized, Controlled, Double-Blind Trial with <i>Ligilactobacillus salivarius</i> LS01 (DSM 22775) and <i>Bifidobacterium breve</i> B632 (DSM 24706) 

Figure 1 | The Probiotics in Pediatric Asthma Management (PROPAM) Study in the Primary Care Setting: A Randomized, Controlled, Double-Blind Trial with Ligilactobacillus salivarius LS01 (DSM 22775) and Bifidobacterium breve B632 (DSM 24706) 